001     276088
005     20250127091338.0
024 7 _ |a pmc:PMC11751922
|2 pmc
024 7 _ |a 10.1136/bmjopen-2024-087482
|2 doi
024 7 _ |a pmid:39819912
|2 pmid
037 _ _ |a DZNE-2025-00169
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Dörner, Jonas
|0 P:(DE-2719)9002752
|b 0
|e First author
245 _ _ |a Prevalence of delirium in German nursing homes: protocol for a cross-sectional study.
260 _ _ |a London
|c 2025
|b BMJ Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1737452422_32043
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Delirium is a neuropathological syndrome that is associated with several negative outcomes. Nursing home residents are vulnerable to developing delirium. Valid prevalence data and associated factors are not yet available for Germany. Therefore, the aim of the prevalence study of the DeliA project (Delirium in Nursing Homes) is to assess the prevalence of delirium and its associated factors in 750 nursing home residents.Trained registered nurses from each participating nursing home will collect the data in a multicentre cross-sectional study. The inclusion criteria for residents are valid informed consent, age ≥65 years and sufficient language skills. The exclusion criteria are aphasia, coma, deafness or end-of-life status. The 4 'A's Test will be used as the primary measurement. Delirium motor subtypes will be determined using the Delirium Motor Subtype Scale. Covariables for associated factors, including functional impairments, pain, cognitive status and nutritional status, are assessed through standardised measurements. Moreover, data such as prescribed drugs or medical diagnosis, hearing impairment or falls will be assessed from the nursing records. Furthermore, the Drug Burden Index will be calculated, and associated factors will be determined using a logistic regression model. The period for data collection in participating nursing homes is planned for 2 consecutive weeks in April 2024.This study was approved by the Ethics Committee of Witten/Herdecke University (no. 82/2023). Findings will be published in peer-reviewed journals and presented at conferences.https://osf.io/xkfvh/ (DOI 10.17605/OSF.IO/XKFVH).
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Delirium & cognitive disorders
|2 Other
650 _ 7 |a EPIDEMIOLOGIC STUDIES
|2 Other
650 _ 7 |a GERIATRIC MEDICINE
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Nursing Homes: statistics & numerical data
|2 MeSH
650 _ 2 |a Germany: epidemiology
|2 MeSH
650 _ 2 |a Cross-Sectional Studies
|2 MeSH
650 _ 2 |a Prevalence
|2 MeSH
650 _ 2 |a Delirium: epidemiology
|2 MeSH
650 _ 2 |a Delirium: diagnosis
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Homes for the Aged: statistics & numerical data
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Research Design
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
700 1 _ |a Houdelet-Oertel, Alexandre
|0 P:(DE-2719)9002404
|b 1
|u dzne
700 1 _ |a Arslan, Zafer
|b 2
700 1 _ |a Lauer, Romy
|b 3
700 1 _ |a Otte, Ina
|b 4
700 1 _ |a Vollmar, Horst Christian
|0 P:(DE-2719)2259205
|b 5
700 1 _ |a Thürmann, Petra
|0 0000-0001-9724-1422
|b 6
700 1 _ |a Palm, Rebecca
|0 P:(DE-2719)2661160
|b 7
700 1 _ |a Holle, Bernhard
|0 P:(DE-2719)2259175
|b 8
|e Last author
773 _ _ |a 10.1136/bmjopen-2024-087482
|g Vol. 15, no. 1, p. e087482 -
|0 PERI:(DE-600)2599832-8
|n 1
|p e087482
|t BMJ open
|v 15
|y 2025
|x 2044-6055
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/276088/files/DZNE-2025-00169.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/276088/files/DZNE-2025-00169.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:276088
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9002752
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9002404
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2259175
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BMJ OPEN : 2022
|d 2024-12-19
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-01-24T13:10:16Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-01-24T13:10:16Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-19
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-19
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-19
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Open peer review
|d 2024-01-24T13:10:16Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-19
920 1 _ |0 I:(DE-2719)1610002
|k AG Holle
|l Care Structures
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1610002
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21